Loading...
ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma
PURPOSE: The purpose of this study was to explore the frequencies of ALK and ROS1 fusion genes in EGFR-mutant lung adenocarcinoma patients and examine the therapeutic efficacies of EGFR-tyrosine kinase inhibitors (TKIs). MATERIALS AND METHODS: A total of 421 EGFR-mutated patients taking EGFR-TKIs we...
Saved in:
| Published in: | Onco Targets Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5513887/ https://ncbi.nlm.nih.gov/pubmed/28744144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S133349 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|